Nevertheless, in certain patients with breast, melanoma and ovarian cancers as well as in preclinical animal models, encouraging effects have been observed when using IFNα, IFNβ, or IFNγ31,55–58. The gene discussed is IFNA1; the disease is ovarian cancer.